Gresham House Ventures, a growth equity investor specialising in software and digitally drivenbusinesses in the technology, consumer, healthcare and services sectors, has completed a £3.5mninvestment into product sustainability impact software business Dayrize. Founded in the Read More
Cambridge, UK, 22nd May 2023 – PharmEnable, a drug discovery company focused on chemical novelty, diversity and complexity, announces it has closed a Pre-Series A investment round of $7.5M to develop the next generation of small molecule Read More